Testimony on reasonable royalty to license patent for EpiPen
Randy Heeb testified at a bench trial on behalf of Seedlings Life Science Ventures, LLC in litigation against Pfizer. The case involved Pfizer’s alleged patent infringement in its use of the EpiPen, its product for treating severe allergic reactions. Dr. Heeb testified regarding the reasonable royalty that Pfizer would have paid Seedlings to license the relevant patent, based on a model of a hypothetical negotiation between the parties.